Skip to main content
OpenTrials
Completed

NCT Number: NCT01679782

Involvement of Nervous System in Muscle Weakness in COPD Patients

The purpose of this study is to determine whether nervous system alterations and motor drive failure can contribute to muscle weakness in COPD during voluntary movement. If necessary, we will look after the role of nocturnal hypoxia in these alterations.

Completed

Looking for future studies?

Notify Me

Key information

About this study

COPD is a common disease that induces many systemic repercussions. Among these, peripheral muscle dysfunction is particularly deleterious because it leads to the decreases of the level of activity and the quality of life for patients. Movement involves activation of many structures, from the instructor, i.e. the brain, to the effector, i.e. the muscle. Netherless, the studies which have described peripheral muscle dysfunction have been focused on the muscle, so they have proposed a reducing vision of the phenomenon. Other studies have reported cerebral alterations in COPD, like cognitive disturbance, increase of the neuronal conduction time, and decrease of the white matter density, and were associated with chronic hypoxemia. Such alterations are consistent with the existence of a decrease of the central motor drive during voluntary movement in COPD patients. Therefore the study will aim to determine precisely which mechanisms are involved in peripheral muscle dysfunction in copd.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • COPD Patients at stage 2 and 3
  • Healthy sedentary subjects

Exclusion criteria

  • Epilepsy, pace-maker, nervous disorders

Treatment and study plan

Primary outcomes

  1. Level of voluntary activation

    Time frame: 2h

Sponsors and collaborators

Lead sponsor

5 Santé

Other

Collaborators

  • ANRT, National French Agency for Technological Researches
  • M2H laboratory, Montpellier University

Registry information

Official study title

Phase 1 Impact of Nocturnal Desaturations on Central Motor Drive in COPD Patients: A New Insight on the Systemic Effects of the Disease.

Acronym: DesCoM-1

Important dates

Study start
2012
Primary completion
2014
Study completion
2014
First posted
Sep 6, 2012
Registry last updated
Mar 10, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.